dpp 4 inhibitor glp 1 agonist DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits Effect of DPP4 inhibition on
Description
GLP-1 improves adipose tissue glyoxalase activity and capillarization improving insulin sensitivity in type 2 diabetes
The present study aims to investigate comparative dementia risk with initiators of GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors in people with type 2 diabetes aged 60 years, using real-world observational data from primary care practice records in the UK
Ismail R, Cska I
[DOI] [PMC free article] [PubMed] [Google Scholar] 117.Jalleh RJ, Plummer MP, Marathe CS, et al
(c) just about getting by
